AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 266: F911-F918, 1994;
0363-6127/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tufro-McReddie, A.
Right arrow Articles by Gomez, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tufro-McReddie, A.
Right arrow Articles by Gomez, R. A.

AJP - Renal Physiology, Vol 266, Issue 6 911-F918, Copyright © 1994 by American Physiological Society


ARTICLES

Angiotensin II type 1 receptor: role in renal growth and gene expression during normal development

A. Tufro-McReddie, D. W. Johns, K. M. Geary, H. Dagli, A. D. Everett, R. L. Chevalier, R. M. Carey and R. A. Gomez
Department of Pediatrics, University of Virginia, School of Medicine, Charlottesville 22908.

To determine whether angiotensin II (ANG II) modulates renal growth and renin and angiotensin type 1 (AT1) gene expression via AT1 during development, weanling rats were given ANG II antagonist losartan (DuP 753) for 3 wk. Body weight (g), kidney weight (g), and kidney weight-to-body weight ratio were lower in losartan-treated rats (162 +/- 7, 1.6 +/- 0.06, and 9.5 +/- 0.1 x 10(-3)) than in control rats (184 +/- 5, 1.8 +/- 0.07, and 10.1 +/- 0.1 x 10(-3); P < 0.05). Renal DNA content (mg/kidney) was lower in losartan-treated (2.4 +/- 0.17) than in control rats (3.3 +/- 0.31; P < 0.05), whereas protein-to-DNA and RNA-to-DNA ratios were similar in losartan-treated and control rats. Renin mRNA levels were sevenfold higher in losartan-treated than in control rats, as determined by quantitative standardized dot blot analysis. In addition, blockade of AT1 with losartan induced recruitment of renin-synthesizing and renin-containing cells in the renal vasculature, as determined by immunocytochemistry and in situ hybridization. To establish whether AT1 blockade has a direct effect on renin gene expression, freshly isolated renin-producing cells were exposed in vitro to losartan (10(-6) M) or culture media (control). Losartan induced a twofold increase in steady-state renin mRNA levels above control (P < 0.05). Intrarenal AT1 mRNA levels were not altered by losartan given either in vivo or in vitro to freshly dispersed cells. To define whether immature renin-secreting cells are responsive to ANG II, renin release was determined by reverse hemolytic plaque assay.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Stubbe, K. Madsen, F. T. Nielsen, R. K. Bonde, O. Skott, and B. L. Jensen
Postnatal adrenalectomy impairs urinary concentrating ability by increased COX-2 and leads to renal medullary injury
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F780 - F789.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. O. Chen, M. H. Park, M. S. Forbes, B. A. Thornhill, S. C. Kiley, K. H. Yoo, and R. L. Chevalier
Angiotensin-converting enzyme inhibition aggravates renal interstitial injury resulting from partial unilateral ureteral obstruction in the neonatal rat
Am J Physiol Renal Physiol, March 1, 2007; 292(3): F946 - F955.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Harrison-Bernard, C. J. Monjure, and B. J. Bivona
Efferent arterioles exclusively express the subtype 1A angiotensin receptor: functional insights from genetic mouse models
Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1177 - F1186.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
T. H. Le, M. I. Oliverio, H.-S. Kim, H. Salzler, R. C. Dash, D. N. Howell, O. Smithies, S. Bronson, and T. M. Coffman
A {gamma}GT-AT1A receptor transgene protects renal cortical structure in AT1 receptor-deficient mice
Physiol Genomics, August 11, 2004; 18(3): 290 - 298.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Stubbe, B. L. Jensen, S. Bachmann, P. Morsing, and O. Skott
Cyclooxygenase-2 contributes to elevated renin in the early postnatal period in rats
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2003; 284(5): R1179 - R1189.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Harrison-Bernard, A. K. Cook, M. I. Oliverio, and T. M. Coffman
Renal segmental microvascular responses to ANG II in AT1A receptor null mice
Am J Physiol Renal Physiol, March 1, 2003; 284(3): F538 - F545.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. J. Mangrum, R. A. Gomez, and V. F. Norwood
Effects of AT1A receptor deletion on blood pressure and sodium excretion during altered dietary salt intake
Am J Physiol Renal Physiol, September 1, 2002; 283(3): F447 - F453.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. L. Draper, J. Wang, N. Valego, W. A. Block Jr., and J. C. Rose
Effect of renal denervation on renin gene expression, concentration, and secretion in mature ovine fetus
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2000; 279(1): R263 - R270.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. E. Giammattei, J. W. Strandhoy, and J. C. Rose
Regulation of in vitro renin secretion by ANG II feedback manipulation in vivo in the ovine fetus
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R1230 - R1238.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. GURON, N. MARCUSSEN, A. NILSSON, B. SUNDELIN, and P. FRIBERG
Postnatal Time Frame for Renal Vulnerability to Enalapril in Rats
J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1550 - 1560.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. I. Oliverio, K. Madsen, C. F. Best, M. Ito, N. Maeda, O. Smithies, and T. M. Coffman
Renal growth and development in mice lacking AT1A receptors for angiotensin II
Am J Physiol Renal Physiol, January 1, 1998; 274(1): F43 - F50.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. A. Karginova, E. S. Pentz, I. G. Kazakova, V. F. Norwood, R. M. Carey, and R. A. Gomez
Zis: a developmentally regulated gene expressed in juxtaglomerular cells
Am J Physiol Renal Physiol, November 1, 1997; 273(5): F731 - F738.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Ozono, Z.-Q. Wang, A. F. Moore, T. Inagami, H. M. Siragy, and R. M. Carey
Expression of the Subtype 2 Angiotensin (AT2) Receptor Protein in Rat Kidney
Hypertension, November 1, 1997; 30(5): 1238 - 1246.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. W. Thompson, S. B. Smith, and C. D. Sigmund
Regulation of Human Renin mRNA Expression and Protein Release in Transgenic Mice
Hypertension, August 1, 1996; 28(2): 290 - 296.
[Abstract] [Full Text]


Home page
NEJMHome page
T. L. Goodfriend, M. E. Elliott, and K. J. Catt
Angiotensin Receptors and Their Antagonists
N. Engl. J. Med., June 20, 1996; 334(25): 1649 - 1655.
[Full Text] [PDF]


Home page
HypertensionHome page
I. V. Yosipiv and S. S. El-Dahr
Activation of Angiotensin-Generating Systems in the Developing Rat Kidney
Hypertension, February 1, 1996; 27(2): 281 - 286.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online